Genetics
Fatty acid length predicts Parkinson's disease risk
Whether or not someone develops Parkinson's disease may be a game of nanometers.
Dec 8, 2021
0
80
Page 4 - News tagged with alpha synuclein
Medications
Combination therapy reduces toxic aggregates in Parkinson's disease
A new combination of drugs could fix the broken lysosomal enzyme pathway in Parkinson's disease-afflicted brain cells, according to a Northwestern Medicine study published in Neuron.
Nov 24, 2021
0
88
Parkinson's & Movement disorders
Frontrunner target for Parkinson's Disease may only be relevant for small fraction of patients
Parkinson's Disease develops if a certain anti-viral receptor and its protein in the brain, called the interferon-beta pathway, is not functioning correctly. That causes the pathway to be blocked, and as a result the brain ...
Oct 8, 2021
1
13
Medications
Early-stage drug candidate diminishes deficits in Parkinson's disease
University of Utah Health scientists have identified a molecule that slows cells' production of alpha-synuclein, a protein that forms toxic aggregates in the brains of people with Parkinson's disease. Its discovery points ...
Sep 21, 2021
0
67
Alzheimer's disease & dementia
New information on the early stages of dementia with Lewy bodies
Results obtained in a study recently completed at the University of Helsinki and Helsinki University Hospital reinforce the notion that dementia with Lewy bodies can be pathologically classified into two different disease ...
Sep 8, 2021
0
12
Parkinson's & Movement disorders
How a Parkinson's disease-linked protein attacks a cell's powerhouses
Inside cells, organelles called mitochondria carry out a medley of vital tasks. These structures generate energy and help to keep the cells' interior environment in a state of healthy equilibrium, among other functions.
Aug 18, 2021
0
290
Neuroscience
Researchers ID location on brain protein linked to Parkinson's disease development
Johns Hopkins Medicine researchers say they have pinpointed the section of alpha-synuclein, a protein in the brain that causes it to latch onto brain cells called neurons and likely drives the development of Parkinson's disease, ...
Jul 29, 2021
0
593
Neuroscience
Will reduction in tau protein protect against Parkinson's and Lewy body dementias?
A new study, published in the journal eNeuro, suggests the answer is no. If this is borne out, that result differs from Alzheimer's disease, where reducing endogenous tau levels in brain neurons is protective for multiple ...
Jun 18, 2021
0
16
Parkinson's & Movement disorders
Understanding gut inflammation may hold clues to mitigating Parkinson's onset
Chronic inflammation in the gut may propel processes in the body that give rise to Parkinson's disease, according to a study by scientists at Van Andel Institute and Roche.
Jun 9, 2021
0
2
Parkinson's & Movement disorders
Discovery may point to Parkinson's disease therapies
A new discovery by University of Guelph researchers may ultimately help in devising new therapies and improving quality of life for people with Parkinson's disease.
May 27, 2021
0
10
